S

Switchpoint Bio

HealthDiagnostics

Switchpoint Bio has raised €4.75 million to decode disease and drug response through blood tests. The company aims to provide insights into patient health and treatment efficacy using advanced diagnostic methods.

Total raised
Undisclosed
tracked to date
Latest round
€4.75 million
Nov 11, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    €4.75 millionNov 11, 2026
    Announcement ↗

Switchpoint Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile